Linzagolix
Linzagolix is a gonadotropin-releasing hormone antagonist (GnRH antagonist) that is used in the treatment of endometriosis and uterine fibroids. It is developed by ObsEva, a Swiss biopharmaceutical company.
Mechanism of action[edit]
Linzagolix works by blocking the gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. This prevents the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn reduces the production of estrogen by the ovaries. The reduction in estrogen levels helps to shrink endometriosis lesions and uterine fibroids.
Clinical trials[edit]
Linzagolix has undergone several clinical trials to evaluate its safety and efficacy. The Phase 3 EDELWEISS trial evaluated the efficacy and safety of linzagolix in women with endometriosis-associated pain. The PRIMROSE trials evaluated the efficacy and safety of linzagolix in women with heavy menstrual bleeding associated with uterine fibroids.
Side effects[edit]
Common side effects of linzagolix include hot flashes, insomnia, and mood swings. Less common but more serious side effects can include bone loss due to the reduction in estrogen levels.
See also[edit]
| GnRH antagonists | ||||||
|---|---|---|---|---|---|---|
This GnRH antagonist related article is a stub.
|
| Endometriosis | ||||||||
|---|---|---|---|---|---|---|---|---|
This Endometriosis related article is a stub.
|
0
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
Linzagolix chemical structure -
Linzagolix molecule ball-and-stick model
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
